Relationship between blood levels of methyl donor and folate and mild cognitive impairment in Chinese patients with type 2 diabetes: A case-control study

Journal of Clinical Biochemistry and Nutrition

Volumn 54, Issue 2, 2014, Pages 122-128

  Zheng, Miaoyan ^a,b   Zhang, Meilin ^a   Yang, Juhong ^b   Zhao, Shijing ^a   Qin, Shanchun ^a   Chen, Hui ^a   Gao, Yuxia ^b   Huang, Guowei ^a  

^a School of Public Health   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Folate; Methyl donor; Mild cognitive impairment; Type 2 diabetes

Indexed keywords

FOLIC ACID; S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE;

AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; FEMALE; FOLIC ACID BLOOD LEVEL; GERIATRIC PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; METHYLATION; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; SMOKING;

EID: 84897564607     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.13-89     Document Type: Article

References (43)

1. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256: 183-194. (Pubitemid 39222988)
2. Luchsinger JA, Reitz C, Patel B, Tang MX, Manly JJ, Mayeux R. Relation of diabetes to mild cognitive impairment. Arch Neurol 2007; 64: 570-575. (Pubitemid 46588347)
3. Profenno LA, Porsteinsson AP, Faraone SV. Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biol Psychiatry 2010; 67: 505-512.
4. Strachan MW, Reynolds RM, Marioni RE, Price JF. Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat Rev Endocrinol 2011; 7: 108-114.
5. Bakulski KM, Dolinoy DC, Sartor MA, et al. Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex. J Alzheimers Dis 2012; 29: 571-588.
6. Fuso A, Seminara L, Cavallaro RA, D'Anselmi F, Scarpa S. S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production. Mol Cell Neurosci 2005; 28: 195-204. (Pubitemid 39656023)
7. Mastroeni D, Grover A, Delvaux E, Whiteside C, Coleman PD, Rogers J. Epigenetic changes in Alzheimer's disease: decrements in DNA methylation. Neurobiol Aging 2010; 31: 2025-2037.
8. Mastroeni D, McKee A, Grover A, Rogers J, Coleman PD. Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer's disease. PLoS One 2009; 4: e6617.
9. Iwata A, Nagata K, Hatsuta H, et al. Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation. Hum Mol Genet 2013; in print.
10. Fuso A, Cavallaro RA, Nicolia V, Scarpa S. PSEN1 promoter demethylation in hyperhomocysteinemic TgCRND8 mice is the culprit, not the consequence. Curr Alzheimer Res 2012; 9; 527-535.
11. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998; 55: 1449-1455. (Pubitemid 28525506)
12. Bi XH, Zhao HL, Zhang ZX, Zhang JW. Association of RFC1 A80G and MTHFR C677T polymorphisms with Alzheimer's disease. Neurobiol Aging 2009; 30: 1601-1607.
13. Sibani S, Melnyk S, Pogribny IP, et al. Studies of methionine cycle intermediates (SAM, SAH), DNA methylation and the impact of folate deficiency on tumor numbers in Min mice. Carcinogenesis 2002; 23: 61-65. (Pubitemid 34213552)
14. Smith DE, Smulders YM, Blom HJ, et al. Determinants of the essential one-carbon metabolism metabolites, homocysteine, S-adenosylmethionine, S-adenosylhomocysteine and folate, in cerebrospinal fluid. Clin Chem Lab Med 2012; 50: 1641-1647.
15. Bottiglieri T, Godfrey P, Flynn T, Carney MW, Toone BK, Reynolds EH. Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. J Neurol Neurosurg Psychiatry 1990; 53: 1096-1098.
16. Morrison LD, Smith DD, Kish SJ. Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease. J Neurochem 1996; 67: 1328-1331. (Pubitemid 26277949)
17. Selley ML. A metabolic link between S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in Alzheimer's disease. Neurobiol Aging 2007; 28: 1834-1839. (Pubitemid 47542535)
18. Villeneuve LM, Natarajan R. The role of epigenetics in the pathology of diabetic complications. Am J Physiol Renal Physiol 2010; 299: F14-F25.
19. Yun KU, Ryu CS, Lee JY, et al. Hepatic metabolism of sulfur amino acids in db/db mice. Food Chem Toxicol 2013; 53: 180-186.
20. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553. (Pubitemid 28319935)
21. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
22. Lee J, Lam L, Woo J, Kwok T. Lower fluid and fruits/vegetable intake in questionable dementia among older Hong Kong Chinese. J Nutr Health Aging 2010; 14: 45-49.
23. Wang H, Chen K, Pan Y, Jing F, Liu H. Associations and impact factors between living arrangements and functional disability among older Chinese adults. PLoS One 2013; 8: e53879.
24. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001; 58: 1985-1992. (Pubitemid 33143977)
25. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-III-R. Arlington: American Psychiatric Association, 1987.
26. Poirier LA, Wise CK, Delongchamp RR, Sinha R. Blood determinations of S-adenosylmethionine, S-adenosylhomocysteine, and homocysteine: correlations with diet. Cancer Epidemiol Biomarkers Prev 2001; 10: 649-655. (Pubitemid 32703199)
27. Unverzagt FW, McClure LA, Wadley VG, et al. Vascular risk factors and cognitive impairment in a stroke-free cohort. Neurology 2011; 77: 1729-1736.
28. Kennedy BP, Bottiglieri T, Anting E, Ziegler MG, Hansen LA, Masliah E. Elevated S-adenosylhomocysteine in Alzheimer brain: influence on methyltransferases and cognitive function. J Neural Transm 2004; 111: 547-567. (Pubitemid 38478922)
29. Hooijmans CR, Blom HJ, Oppenraaij-Emmerzaal D, Ritskes-Hoitinga M, Kiliaan AJ. S-adenosylmethionine and S-adenosylhomocysteine levels in the aging brain of APP/PS1 Alzheimer mice. Neurol Sci 2009; 30: 439-445.
30. Robbins MA, Elias MF, Budge MM, Brennan SL, Elias PK. Homocysteine, type 2 diabetes mellitus, and cognitive performance: The Maine-Syracuse Study. Clin Chem Lab Med 2005; 43: 1101-1106. (Pubitemid 41581968)
31. Hooshmand B, Solomon A, Kireholt I, et al. Associations between serum homocysteine, holotranscobalamin, folate and cognition in the elderly: a longitudinal study. J Intern Med 2012; 271: 204-212.
32. Linnebank M, Popp J, Smulders Y, et al. S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease. Neurodegener Dis 2010; 7: 373-378.
33. Chishty M, Reichel A, Abbott NJ, Begley DJ. S-adenosylmethionine is substrate for carrier mediated transport at the blood-brain barrier in vitro. Brain Res 2002; 942: 46-50. (Pubitemid 34597067)
34. Mulder C, Schoonenboom NS, Jansen EE, et al. The transmethylation cycle in the brain of Alzheimer patients. Neurosci Lett 2005; 386: 69-71. (Pubitemid 41058933)
35. Nieman KM, Rowling MJ, Garrow TA, Schalinske KL. Modulation of methyl group metabolism by streptozotocin-induced diabetes and all-trans-retinoic acid. J Biol Chem 2004; 279: 45708-45712. (Pubitemid 39491560)
36. Fuso A, Nicolia V, Cavallaro RA, Scarpa S. DNA methylase and demethylase activities are modulated by one-carbon metabolism in Alzheimer's disease models. J Nutr Biochem 2011; 22: 242-251.
37. Coppede F. One-carbon metabolism and Alzheimer's disease: focus on epigenetics. Curr Genomics 2010; 11: 246-60.
38. Fuso A, Nicolia V, Cavallaro RA, et al. B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteine, depletes brain S-adenosylmethionine, and enhances PS1 and BACE expression and amyloid-beta deposition in mice. Mol Cell Neurosci 2008; 37: 731-746.
39. Levkovitz Y, Alpert JE, Brintz CE, Mischoulon D, Papakostas G1. Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder. J Affect Disord 2012; 136: 1174-1178.
40. Partearroyo T, Pérez-Miguelsanz J, Úbeda N, Valencia-Benítez M, Alonso-Aperte E, Varela-Moreiras G. Dietary folic acid intake differentially affects methionine metabolism markers and hippoccampus morphology in aged rats. Eur J Nutr 2013; 52: 1157-1167.
41. Herrmann W, Schorr H, Obeid R, Makowski J, Fowler B, Kuhlmann MK. Disturbed homocysteine and methionine cycle intermediates S-adenosylhomocysteine and S-adenosylmethionine are related to degree of renal insufficiency in type 2 diabetes. Clin Chem 2005; 51: 891-897. (Pubitemid 40577927)
42. Park EI, Garrow TA. Interaction between dietary methionine and methyl donor intake on rat liver betaine-homocysteine methyltransferase gene expression and organization of the human gene. J Biol Chem 1999; 274: 7816-7824.
43. Lever M, Slow S, McGregor DO, Dellow WJ, George PM, Chambers ST. Variability of plasma and urine betaine in diabetes mellitus and its relationship to methionine load test responses: an observational study. Cardiovasc Diabetol 2012; 11: 34.